Advanced search
Publication Cover
Future Oncology Volume 16, 2020 - Issue 15
Submit an article Journal homepage
245
Views
13
CrossRef citations to date
0
Altmetric
Review

Predictive Markers of Immune Response in Glioblastoma: Hopes and Facts

Vincenzo Di Nunno1 Department of Medical Oncology,Azienda USL/IRCCS Institute of Neurological Sciences,Bologna,ItalyCorrespondence[email protected]
,
Enrico Franceschi1 Department of Medical Oncology,Azienda USL/IRCCS Institute of Neurological Sciences,Bologna,Italy
,
Lidia Gatto1 Department of Medical Oncology,Azienda USL/IRCCS Institute of Neurological Sciences,Bologna,Italy
,
Stefania Bartolini1 Department of Medical Oncology,Azienda USL/IRCCS Institute of Neurological Sciences,Bologna,Italy
&
Alba Ariela Brandes1 Department of Medical Oncology,Azienda USL/IRCCS Institute of Neurological Sciences,Bologna,Italy
Pages 1053-1063 | Received 19 Jan 2019, Accepted 24 Mar 2020, Published online: 09 Apr 2020

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini & Alba Ariela Brandes. (2022) Hypermutation as a Potential Predictive Biomarker of Immunotherapy Efficacy in High-Grade Gliomas: A Broken Dream?. Immunotherapy 14:10, pages 799-813.
Read now
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto & Alba Ariela Brandes. (2022) BET Inhibitors: the Promise of a New Generation of Immunotherapy in Glioblastoma. Immunotherapy 14:3, pages 169-172.
Read now
Ilaria Maggio, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Vincenzo Di Nunno, Caterina Tonon & Alba A. Brandes. (2021) Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light. Expert Review of Anticancer Therapy 21:11, pages 1265-1272.
Read now
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Monica Di Battista, Lidia Gatto, Cinzia Lamperini, Santino Minichillo, Antonella Mura, Stefania Bartolini & Alba A. Brandes. (2020) Treatment of recurrent glioblastoma: state-of-the-art and future perspectives. Expert Review of Anticancer Therapy 20:9, pages 785-795.
Read now

Articles from other publishers (9)

Zheng Huo, LiShuo Guo, Wei Shao, Qian Ding, Yue Guo & Qian Xu. (2023) CRNDE, an enhancer RNA of prognostic value in glioma, correlates with immune infiltration: A pan-cancer analysis. European Journal of Inflammation 21, pages 1721727X2211380.
Crossref
Berta Segura-Collar, Sara Hiller-Vallina, Olaya de Dios, Marta Caamaño-Moreno, Lucia Mondejar-Ruescas, Juan M. Sepulveda-Sanchez & Ricardo Gargini. (2023) Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators. Acta Neuropathologica Communications 11:1.
Crossref
Wentao Hu, Hongyu Liu, Ze Li, Jialin Liu & Ling Chen. (2022) Impact of molecular and clinical variables on survival outcome with immunotherapy for glioblastoma patients: A systematic review and meta‐analysis. CNS Neuroscience & Therapeutics 28:10, pages 1476-1491.
Crossref
Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Stefania Bartolini & Alba Ariela Brandes. (2022) Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?. Drugs 82:5, pages 491-510.
Crossref
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Stefania Bartolini & Alba Ariela Brandes. (2022) Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance. Frontiers in Oncology 12.
Crossref
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Ilaria Maggio, Raffaele Lodi, Stefania Bartolini & Alba A. Brandes. (2021) Immune-checkpoint inhibitors in pituitary malignancies. Anti-Cancer Drugs 33:1, pages e28-e35.
Crossref
Zijiang Yang, Weiyi Gong, Ting Zhang & Heng Gao. (2021) Molecular Features of Glioma Determined and Validated Using Combined TCGA and GTEx Data Analyses. Frontiers in Oncology 11.
Crossref
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Raffaele Lodi, Stefania Bartolini & Alba Ariela Brandes. (2021) Glioblastoma: Emerging Treatments and Novel Trial Designs. Cancers 13:15, pages 3750.
Crossref
Jared Mamrot, Nathan E. Hall & Robyn A. Lindley. (2021) Predicting clinical outcomes using cancer progression associated signatures. Oncotarget 12:8, pages 845-858.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.